Weight Loss Drugs Raise Reflux Risk
A British study indicates that weight loss and diabetes medications such as Ozempic and Mounjaro increase the rate of reflux and pulmonary aspiration during anesthesia by 11 times. Prior disclosure of the use of these medications before surgical procedures is required, as it has been shown that users are more susceptible to respiratory complications during recovery, although the absolute risk remains low. The study involved over 47,000 patients in the United Kingdom and found that 40% of individuals obtain these medications through online pharmacies without direct medical supervision.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)